Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.

Similarly in the treatment-regimen estimand (estimated average treatment effect regardless of treatment discontinuation or additional antihyperglycemic medication initiation), all doses of ...

When healthcare providers are deciding between escalating the dose of existing medications and switching antihyperglycemic agents, there are various factors to consider, the researchers advised.

Because antihyperglycemic medications that increase insulin sensitivity improve the underlying defect of insulin resistance and type 2 diabetes mellitus, they have the potential to slow or ...

Not all diabetes medications cause weight gain, but some might. Others may be weight neutral or cause weight loss. Find out more in this article.

The notion is that GLP-1RAs have been shown to slow retinal ganglion cell death and may reduce risk for developing glaucoma in people with diabetes vs. other antihyperglycemic medications.

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.

Zituvimet XR is a combination of sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin hydrochloride, a biguanide.

Researchers compare the effectiveness of anti-diabetes medications in reducing the risk of dementia in older diabetics.

When stratified by classes of antihyperglycemic medications, patients taking newer drug classes tended to be more likely to have hypercortisolism: Tirzepatide: OR 1.820 (95% CI 1.187-2.790) ...

Part one of the CATALYST trial enrolled 1,055 adults aged 18 to 80 years with type 2 diabetes who had an HbA1c between 7.5% and 11.5% and were taking three or more antihyperglycemic drugs, insulin ...

There was an ensuing flurry of cardiovascular safety trials for all new antihyperglycemic agents. These trials typically compared the new agent with a control group using a matching placebo, with ...